Calcium channel genes associated with bipolar disorder modulate lithium's amplification of circadian rhythms, Neuropharmacology (2015), doi: 10.1016/j.neuropharm.2015.10.017. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Knockdown of CACNA1A or CACNB3 altered baseline rhythms, but did not affect rhythm amplification by lithium. In human fibroblasts, CACNA1C genotype predicted the amplitude response to lithium, and the expression profiles of CACNA1C, CACNA1D and CACNB3 were altered in BD vs. controls. We conclude that in cells from BD patients, calcium signaling is abnormal, and that LTCCs underlie the failure of lithium to amplify circadian rhythms.
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INTRODUCTION
Bipolar Disorder (BD) is a common mood disorder defined by alternating periods of depression and mania/hypomania, leading to disability and elevated risk of suicide (Oquendo et al., 2010) .
It is estimated that BD is 70-85% heritable, suggesting a genetic basis for the disorder (McGuffin et al., 2003) . Other hallmarks of BD include disrupted behavioral rhythms, with inappropriate timing of activity, sleep, and appetite, indicating that circadian rhythm abnormalities may underlie BD . Additional evidence linking circadian rhythms to BD comes from lithium. Lithium corrects the mood, activity and sleep disturbances in BD, and alters circadian rhythms. In humans (Kripke et al., 1979) and animals (Kripke and Wyborney, 1980; Welsh and Moore-Ede, 1990) , lithium lengthens the rhythm period; and in cells, increases rhythm amplitude . A set of ~20 "clock genes" (e.g.
PER1/2, CLOCK and ARNTL)
form the core of the circadian clock (Partch et al., 2014) . Since BD is largely attributed to genetic factors, clock genes have been studied as susceptibility loci for BD. We previously identified circadian rhythm abnormalities in skin fibroblasts from BD patients. In particular, BD cells showed diminished capacity to amplify cellular circadian rhythms in response to lithium, with individual variation partly explained by a polymorphism in GSK3B (McCarthy et al., 2013) . However, the mechanism by which lithium differentially increases amplitude in BD remains incompletely characterized. Since low rhythm amplitude may be one of the key rhythm abnormalities associated with BD (Jones et al., 2005; Gonzalez et al., 2014; McKenna et al., 2014) , the cellular basis of amplitude modulation warrants investigation.
Ca
2+ and the circadian clock have bidirectional interactions in neurons and peripheral cells (Noguchi et al., 2012; Ikeda, 2014; Schmutz et al., 2014) . Hence, failure of lithium to amplify circadian rhythms in BD could be caused by altered Ca 2+ clock inputs, or by clock outputs that perturb Ca 2+ rhythms. Acutely, lithium activates intracellular Ca 2+ release by inhibiting inositol monophophatases, and stimulating inositol 1,4,5 tris-phosphate (IP3). Chronic lithium has the opposite effect, decreasing basal and stimulated intracellular Ca 2+ , possibly by depleting cells of myo-inositol (Chen and Hertz, 1996; Yan et al., 2013) . Lithium also inhibits glycogen synthase kinase β (GSK3B), a post-translational regulator of both LTCCs (Li and Sarna, 2011) and the circadian clock (Harada et al., 2005; Iitaka et al., 2005; Yin et al., 2006; Sahar et al., 2010) .
Genome wide association studies indicate that clock gene variants are only weakly associated with BD Byrne et al., 2014) . In contrast, L-type Ca 2+ channels (LTCCs) have been identified as important BD susceptibility genes (PGC-BD, 2011) . Among Ca 2+ M A N U S C R I P T
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2 channel genes, CACNA1C is most strongly implicated, with the C allele at the G/C polymorphism rs4765913 conferring risk for BD. Suggestive associations in CACNA1D, CACNB3 have also been identified (PGC-BD, 2011; Nurnberger et al., 2014) . Calcium channels are classified according to their pore-forming α1 subunit, while accessory β and α2δ subunits are shared across multiple channels. CACNA1C and CACNA1D encode the α1 subunits for two LTCCs, Cav1.2 and Cav1.3, whereas CACNB3 encodes a β3 subunit. Previous studies have examined Ca 2+ signaling in BD cells (Hahn et al., 2005; Chen et al., 2014) , but few have linked abnormalities to particular LTCCs identified as genetic risk factors. Among investigations of CACNA1C, there is conflicting evidence as to whether BD-associated variation causes gain or loss of function. A recent study using human induced neurons homozygous for the variant risk allele reported that CACNA1C expression was increased, with corresponding increases in electrical activity (Yoshimizu et al., 2015) . A previous post-mortem brain study came to the opposite conclusion, reporting decreased CACNA1C expression associated with the BD risk allele (Gershon et al., 2014) . Therefore, BD-associated variants in LTCCs remain incompletely characterized in cellular models of BD.
We examined the hypothesis that the weak amplitude response to lithium in BD cells could be explained by loss of function in LTCCs, resulting in weak Ca 2+ inputs to the circadian clock. We found that fibroblasts from BD patients were sufficient to model some aspects of LTCC function as they relate to circadian rhythms. Using molecular reporters to study Ca 2+ and circadian rhythms in these cells, we investigated genetic and molecular connections among LTCCs, lithium and the clock, and determined that lithium engages Ca 2+ . Over the short term, the intracellular Ca 2+ response is blunted in BD cells independently of LTCCs. Over hours-days, LTCCs regulate cellular circadian rhythms, and CACNA1C is involved with the lithium-induced amplification of rhythms. Finally, some LTCCs appear to be clock controlled genes, with altered features of expression in BD.
METHODS
Human Subjects. Punch biopsies were obtained from the skin over the deltoid from BD (type I) patients who consented to research while hospitalized, or participating in a lithium clinical trial.
Demographic characteristics of donors are shown in Table S1 . Controls and BD donors did not differ in mean age or sex distribution. The majority of donors were Caucasian, and most BD M A N U S C R I P T
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3 patients (94%) were on medication at the time of biopsy. Use of human subjects was conducted in accordance with all pertinent regulations and approved by the VASDHS IRB.
Cell Culture. Human fibroblasts were grown from frozen cryovials to confluence in 100 mm plates in standard culture media [DMEM with 10% fetal boving serum (FBS), glutamine 2mM
and antibiotics (penicillin, streptomycin, and amphotericin)]. In order to control for differences in donors' medication history, all cells were passaged a minimum of four times before use. Per2 expression reflects network activity across the circadian clock (Welsh et al., 2005) . Therefore, human fibroblasts were transduced with the Per2::luc lentiviral reporter gene to assess circadian rhythms as described previously (McCarthy et al., 2013) . In order to facilitate screening of drugs and siRNAs in a cell type comparable to human fibroblasts, we developed a mouse fibroblast line that stably expressed the Per2::luc reporter (NIH3T3
P2L
), using a construct described previously (Meng et al., 2008 Luminometry. Human fibroblast rhythms were recorded from 35 mm plates over 5 days with a luminometer (Actimetrics) as described previously (McCarthy et al., 2013) . NIH3T3 P2L rhythms
were measured using 4x24 well plate format luminometer (Actimetrics) over 5-7 days. Both luminometers were housed in a dry incubator and maintained in room air at 35°C. Immediately before rhythm recording, media was replaced with HEPES-buffered, serum-free recording media containing 1 mM luciferin (Biosyth International). To model therapeutic conditions, in some experiments drugs were added 48 hr before, and again at the addition of recording media, to maintain constant concentrations throughout the experiment.
Rhythm Analysis. Photoemissions (counts per second) from each sample were recorded every 10 minutes over the duration of the experiment and logged automatically for subsequent analyses. To reduce variability, the first 14 hr (human) or 24 hr (mouse) were excluded.
Background subtracted luminometry data were fit to a damped sine curve by the least squares method using commercial software (Lumicycle Analysis). Rhythm parameters (period, amplitude) were estimated for each trace and averaged across replicates. For analyses of drug and siRNA effects, two-way ANOVA with post-hoc t-tests were conducted separately for amplitude and period. All analyses were completed using GraphPad Prism version 5.0 (San Diego, CA) with α <0.05. SNPs were genotyped with pre-designed Taqman assays (Applied Biosystems) using real time polymerase chain reaction (PCR). Due to scarcity of homozygotes for the minor alleles, heterozygotes and minor allele homozygotes were combined for the analyses and termed "carriers" for each allele.
Genetic Association Study of Amplitude. In human cells, Per2::luc gene expression rhythms were recorded under baseline and lithium-treated conditions. Amplitude was measured simultaneously under both conditions for each individual. The average change in amplitude was then compared between two groups: homozygotes for the common allele and minor allele carriers for the CACNA1C variant. A two-way ANOVA with α <0.05 was used to determine statistical significance.
Gene Expression. For the time course analyses, fibroblasts (N=3 control, n=4 BD) were grown in parallel in six-well plates. Among risk allele carriers, three were heterozygous for rs4765913, one was homozygous for the BD-associated C allele. The latter cell line was selected for the rare CACNA1C genotype, but the donor's diagnosis of BD was uncertain, with reported symptoms (clinically significant depression), and positive family history of BD in multiple 1 st degree relatives. Serum shock (DMEM + 50% FBS) was used to synchronize cells 18 hr before the first collection (Balsalobre et al., 1998) . Plates were collected at 4 hr intervals over 12 or 24 hr. Upon collection, cells were rinsed with ice-cold PBS, plates sealed and frozen at -80°C. RNA was prepared using a Qiagen RNeasy kit, following the manufacturer's instructions. cDNA was synthesized using a kit (Applied Biosystems). Taqman RT-PCR was conducted using a BioRad CFX384 thermocycler with pre-made primers for each transcript (Applied Biosystems). CLOCK, and PER1 were used as positive controls and phase markers. GAPDH was used as a nonrhythmic housekeeping control (Kosir et al., 2010) , against which gene expression was measured (Schmittgen and Livak, 2008) . In order to test for the presence of rhythms, 24 hr expression data were fit to a sine wave using specialized software (CircWave, version 1.4).
Rhythms were determined to be present when the resulting curve explained a significant portion of the variance (p<0.05). To evaluate differences in the strength of gene expression rhythms, a
Fisher r to z transformation was used to compare the variance explained by the best fit sine
wave in each group. For microarray studies, human fibroblast RNA was analyzed by the UCSD microarray core facility using the Affymetrix Human 1.0 Array. Expression levels of selected Ca 2+ channel genes were extracted from the full data set for quantification.
RESULTS
Calcium channel genes are expressed in fibroblasts. Ca 2+ channel expression was measured in human fibroblasts. Expression of nineteen Ca 2+ channel genes was detected, including three LTCC α1 subunits (CACNA1C, CACNA1D, CACNA1F), as well as α2δ, β and γ subunits ( Figure S1 ). With multiple pore forming and regulatory subunits expressed, fibroblasts are theoretically capable of forming multiple LTCC combinations. T-type (TTCC, e.g.
CACNA1G)
and P/Q-type (PTCC, e.g. CACNA1A) channels were also readily detectable. Nand R-type channels were absent. Therefore, we determined that fibroblasts are a reasonable model to examine selected interactions between Ca 2+ channels and cellular rhythms. 
LTCC antagonists block lithium's amplification of circadian rhythms in fibroblasts.
Neuronal LTCCs respond slowly, contributing to changes in gene expression after sustained activity (Mermelstein et al., 2000) . We set out to determine if LTCCs play a role in the cellular response to lithium over longer times relevant to circadian rhythms. In long-term (5-7 day) studies of NIH3T3 P2L cells, lithium increased circadian rhythm amplitude by ~30% and lengthened period by ~0.5 hr (Figure 2A-C Figure 2F ). In BD, rhythms largely fail to amplify in response to lithium, confounding the diltiazem studies. Therefore, BD samples were not considered in this experiment. Nonetheless, the control data support a link between LTCCs and lithium that emerges over hours to days to affect circadian rhythms.
Knockdown of CACNA1C and CACNA1D. In order to examine the specific contributions of individual Ca 2+ channel genes to rhythms, we used siRNA to reduce the expression of two BD associated LTCC α1 subunits, CACNA1C ( Figure 3A -C) and CACNA1D (Figure 3D-F) .
Knockdown of ARNTL, an essential component of the clock served as a positive control. After siRNA treatment, we measured rhythms in NIH3T3 P2L cells in the presence or absence of lithium. As expected, ARNTL knockdown led to a near total loss of rhythms in NIH3T3 P2L cells ( Figure S4 ). In the absence of lithium, knockdown of both CACNA1C and CACNA1D led to rhythm amplitude increases (Figure 3B, 3E) . The increases were observed in the mean expression, and amplitude, suggesting increases in both constitutive and rhythmic expression of Per2::luc. The effects were especially strong early in the recording period, and more pronounced for CACNA1C vs. CACNA1D. In response to lithium treatment of the cells, CACNA1C and CACNA1D knockdown attenuated the expected increase in rhythm amplitude.
CACNA1D knockdown with lithium treatment led no change in amplitude, while CACNA1C knockdown caused an amplitude decrease after lithium (Figure 3B, 3E ). Loss of CACNA1C had no effect on period by itself but attenuated the period lengthening effects of lithium ( Figure 3C ).
Knockdown of CACNA1D, despite its lower abundance, had significant effects on period,
shortening it by ~1 hr at baseline, and enhancing the period lengthening properties of lithium (p<0.01 post-hoc T-test, 0.3 hr longer after lithium in negative control vs. 0.9 hr longer after CACNA1D siRNA) ( Figure 3F) .
Knockdown of CACNA1A. To distinguish between effects that are specific to LTCCs and those related to general alterations in Ca 2+ , we performed knockdown of CACNA1A, a PTCC α1 subunit gene that is highly expressed in fibroblasts, but not strongly associated with BD ( Figure   3G ). As with the LTCC α1 genes, CACNA1A knockdown in NIH3T3 P2L cells lead to increased rhythm amplitude ( Figure 3H) . However, unlike the LTCC α1 genes, CACNA1A knockdown did not alter lithium's effect on amplitude ( Figure 3H ). CACNA1A knockdown had no effect on period at baseline, but blocked the ability of lithium to lengthen period ( Figure 3I ).
Knockdown of CACNB3. Finally, to investigate the impact of β subunits on rhythms, we performed CACNB3 knockdown in NIH3T3 P2L cells (Figure 3J-L) . Unlike knockdown of pore forming α1 subunits, amplitude and mean expression decreased after knockdown of the regulatory CACNB3 subunit. Despite being a BD associated channel, lithium maintained its amplitude increasing effect under CACNB3 knockdown conditions ( Figure 3K ). CACNB3 knockdown had no effect on period at baseline or on the period lengthening effect of lithium ( Figure 3L ).
CACNA1C genotype is associated with the amplitude response to lithium. We conducted a rhythm analysis of 12 new fibroblast cell lines (9 BD, 3 controls) under baseline and lithium treated conditions. Data were combined with past results (McCarthy et al., 2013) and used for additional genetic analyses of CACNA1C. As before, there were individual differences in lithiumevoked amplitude increases, but these differences were explained by CACNA1C genotype (p<0.05). Regardless of diagnosis, cells homozygous for the common rs4765913 G allele increased amplitude by ~35%, while in carriers of the BD-associated C allele, amplitude failed to increase ( Figure 4A-C) . Baseline amplitude did not differ between BD cases and controls (McCarthy et al., 2013) or as a function of CACNA1C genotype ( Figure 4C ).
Calcium channel gene expression is altered in BD.
BD is associated with variants that regulate the expression of CACNA1C (Gershon et al., 2014; Yoshimizu et al., 2015) , and several other genes pertinent to Ca 2+ signaling (Ament et al., 2015) . Therefore, we examined CACNA1C, CACNA1D and CACNB3 in fibroblasts to determine if the temporal control of these M A N U S C R I P T
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9 Ca 2+ channels is altered in BD. Expression of CACNA1C in control cells was rhythmic (r 2 best fit sine = 0.71, p<0.001, Figure 5A ). In BD cells, expression was still rhythmic (r 2 best fit sine = 0.25, p<0.05, Figure 5A ), but the rhythm was significantly attenuated compared to controls (Fisher r-to-z test, p<0.05). To examine CACNA1C expression in the context of other Ca 2+ channels and circadian clock genes, an experiment was conducted targeting four additional genes over 12 hr. In accordance with the 24 hr data, CACNA1C expression significantly differed by time in control cells (p<0.05), and was found to be in phase with PER1, and in anti-phase to CLOCK (Fig 5B, 5E ). As before, CACNA1C expression varied weakly over 12 hr in BD cells (effect of time was not significant, p=0.5, Fig 5B) . CACNA1D expression did not vary significantly by time in either group (Fig 5C) , but was more highly expressed (p<0.01) in BD cells compared to controls. In both control and BD cells, CACNB3 expression varied across time, in phase with control CACNA1C expression (Fig 5D) , but with reduced amplitude in BD cells (p<0.005).
DISCUSSION
We have shown that lithium engages Ca 2+ signaling in a temporally complex manner that is altered in BD and/or by BD-associated genetic variation. Our main finding is that CACNA1C modulates the cellular rhythm amplitude response to lithium, providing a specific link between LTCCs and circadian rhythms in the context of BD and lithium. Our results validate past reports linking LTCCs to rhythms (Pennartz et al., 2002; Noguchi et al., 2012; Schmutz et al., 2014) , and extend this work to identify subunit specific roles in rhythm regulation. We conclude that LTCC α1 subunit genes (CACNA1C, and to a lesser extent CACNA1D) selectively influence lithium's effects on rhythm amplitude, while β subunits (CACNB3) and PTCCs (CACNA1A) do not. While we did not focus on circadian period, each of the channels studied had specific effects on this parameter, indicating specialized roles of Ca 2+ channels in modulating circadian rhythms, and suggesting that period and amplitude are independently regulated by distinct systems. Our data imply that lithium triggers a Ca 2+ signaling response that initially does not rely on LTCCs, but recruits LTCCs to an important role over subsequent hours-days. We initially hypothesized that in BD cells, loss of LTCC function and weak Ca 2+ inputs to the circadian clock could underlie the attenuated response of circadian rhythms to lithium. Support for this hypothesis is mixed. We found that the acute Ca 2+ response to lithium is indeed weaker in BD cells, but not because of LTCCs. While we did not identify differences in overall CACNA1C expression, we did find attenuation of its rhythmic expression pattern. Speaking against weak M A N U S C R I P T and circadian rhythms to these essential neuronal functions. There may also be differences between neurons and fibroblasts in lithium sensitivity: Peripheral cells commonly require higher concentrations of lithium (i.e. >10 mM) to induce biological changes than would be therapeutically relevant (i.e. 1 mM). For these reasons, our work must be extrapolated to the brain with caution.
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Genetic variation in CACNA1C and rhythms. The BD-associated CACNA1C haplotype containing rs4765913 is located in intron 2, and presumably affects regulatory sequence.
However, it is unclear if there is a loss or gain of function. Previous studies have linked this haplotype to changes in CACNA1C expression, with decreases reported in brain (Gershon et al., 2014) and increases reported in cultured neurons (Yoshimizu et al., 2015) . Brain imaging studies of CACNA1C show a variety of results that vary with the specific measure and brain region (Ou et al., 2015) . The lack of consensus in findings is not necessarily surprising. Given the many roles of Ca 2+ in various cell types, there may be many consequences of CACNA1C variation, some of which could be cell specific. Therefore, our association of CACNA1C with M A N U S C R I P T
attenuated rhythm amplification by lithium, is most consistent with a loss of channel function in BD, but may not apply universally. It is known that CACNA1C is a clock controlled gene, regulated by ROR elements in the 5' promoter that confer a rhythmic expression profile in the suprachiasmatic nucleus (SCN) in the brain (Schmutz et al., 2014) . Our data extend this previous work to suggest that the BD-associated haplotype may affect this rhythmic expression of CACNA1C in fibroblasts. If variation in CACNA1C causes a similar loss of rhythms in neurons, it may result in abnormal expression patterns, affecting temporal control over Ca flattening the temporal profile of Cav1.2 and β3 subunits. While our data cannot address the issue in detail, we speculate that disrupted LTCC composition in the brain could be one mechanism by which genetic variation in LTCCs predisposes to BD.
The acute Ca 2+ response to lithium. Variability in LTCC genes could affect rhythm amplitude by altering the strength of Ca 2+ signals shortly after lithium administration. We found little support for this hypothesis. BD cells did show a reduced Ca 2+ response to lithium in the seconds following administration. However, the role for LTCCs in this process was modest, showing minimal attenuation with diltiazem. Lithium also inhibits IP3 catabolism, thereby stimulating short-term intracellular Ca 2+ release. However, our studies indicated that IP3 receptors were not involved either. Collectively, these results indicate that BD is characterized by multiple deficits in Ca 2+ signaling that extend beyond LTCCs. PTCCs, TTCCs and ryanodine receptors were detected in fibroblasts, and could also be engaged by lithium. Others have identified genetic variants in non-selective cation channels in BD, with corresponding functional differences in patient cells (Roedding et al., 2012) . Our data indicate that in BD one or more of these non-M A N U S C R I P T
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LTCC channels is also abnormal. Therefore, future experiments on them are warranted to better understand the Ca 2+ landscape in BD.
Pharmacological and genetic disruption of LTCCs. We observed long-lasting effects of diltiazem and LTCC knockdown on rhythm amplitude, but with important differences.
Pharmacological inhibition decreased rhythm amplitude, while CACNA1C/CACNA1D
knockdown increased amplitude. These data agree on the notion that LTCCs regulate the clock, but diverge in direction, suggesting the regulatory mechanisms involved are complex.
CACNA1C and CACNA1D are translated into two proteins (Cav1.2 and Cav1.3) with distinct signaling properties (Zhang et al., 2006; Giordano et al., 2010; Wheeler et al., 2012) , while the majority of LTCC antagonists, including diltiazem and verapamil are non-selective, binding (Ostacher et al., 2014) .
The amplitude enhancing effects of LTCC knockdown are more difficult to explain. Calcium signals typically facilitate the expression of clock genes and so this finding is counterintuitive.
Knockdown of CACNA1C/CACNA1D greatly reduces the amount of α1 protein available to form the corresponding LTCC pore, while leaving intact accessory subunits (e.g. β and α2δ) that are shared across multiple Ca 2+ channel types. Changing the balance of channel subunits through knockdown appears to result in greater Ca 2+ input to the clock and higher amplitude rhythms through an unknown compensatory mechanism. Compensatory changes could include substitution of low activity for high activity α1 subunits, the shunting of Ca 2+ to other channels, or shifts in ion balance driven by electrochemical membrane potential. Given the likelihood of extensive compensation, LTCC knockdown phenotypes may not have a correlate in normal physiology. Nonetheless, after adjusting for the elevated baseline amplitude, they do afford insight into the role of LTCC α1 subunits in response to lithium, and suggest a direct rather than additive/indirect role of LTCCs in linking lithium to circadian rhythm amplitude modulation.
Incorporating LTCCs into the GSK3B model of lithium action. Lithium inhibits GSK3B at therapeutic concentrations (Klein and Melton, 1996) . Accordingly, both lithium and selective pharmacological inhibition of GSK3B increase rhythm amplitude in a similar manner (Li et al., M A N U S C R I P T
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13 2012); and our previous work demonstrated that genetic variation in GSK3B predicted lithium's ability to amplify circadian rhythms in BD cells (McCarthy et al., 2013) . Therefore, considered with the present findings, we conclude that GSK3B and Ca 2+ are both involved in the amplitude enhancing effect of lithium, with inhibition of GSK3B and stimulation of Ca 2+ favoring amplitude increase. Given the complexity of Ca 2+ signaling, the means by which GSK3B and Ca 2+ interact to modulate amplitude are unclear. Calcium affects protein kinase A (PKA), protein kinase C (PKC) and mitogen activated protein kinase (MAPK) pathways (Manji and Lenox, 1999; Stork and Schmitt, 2002) . Therefore upstream direction of these systems by Ca 2+ could converge on, or work in concert with GSK3B to affect the circadian clock. Alternatively, lithium inhibition of GSK3B stabilizes Cav1.2 by reducing protein turnover (Li and Sarna, 2011) , suggesting another way that lithium could amplify Ca 2+ signals. In this case, the effects of Ca 2+ would lie downstream of GSK3B. These mechanisms are not mutually exclusive and could co-occur.
Clinical implications for BD. The master clock in the SCN plays a central role in regulating circadian rhythms (Welsh et al., 2010) . However, the loss of gene expression rhythms in additional, non-SCN brain regions has been reported in post-mortem patients with major depression . These data suggest that loss of rhythms may be a feature of mood disorders that widely affects brain function beyond the SCN, affecting multiple brain oscillators . If this is true, mood symptoms in BD could reflect episodes of low amplitude rhythms in one or more brain areas. We conclude from our past and current results that BD is characterized by rhythms that amplify weakly in response to lithium. This conceptualization has implications for how lithium may be therapeutic in BD. At therapeutic concentrations (1 mM), lithium had no effect on period in BD or control fibroblasts, suggesting this particular effect of lithium, well described in many systems (but often at higher concentrations) is not the basis of its therapeutic effect in BD patients. Instead, the effect on amplitude may be more important. Although the amplitude-enhancing effects of lithium are generally stronger in control than in BD cells, we demonstrated previously that when rhythms are damped, lithium bolsters amplitude equally well in BD and control cells (McCarthy et al., 2013) . Therefore, it may be that lithium is therapeutic specifically in the context of a failing clock, working by improving weak rhythms. In this way, the failure of lithium to bolster high amplitude rhythms in BD may reflect a narrowing of the dynamic range, with maintained action on low amplitude rhythms that could be therapeutically important, but relatively weak effects on higher amplitude rhythms. Because the clinical treatment of our BD subjects was heterogeneous and the therapeutic outcomes are unknown in many cases, we cannot address the issue of M A N U S C R I P T
14 amplitude modulation as it relates to specific treatment outcomes. Nonetheless, our data indicate that amplitude modulation by lithium distinguishes BD and control cells, and may have potential use as a diagnostic biomarker to distinguish BD patients from healthy subjects. The role of rhythms in mood regulation, and the range of amplitude responsiveness in cells are not well studied, and our speculations remain to be tested in future studies. The relationship between rhythm modulation and clinical outcomes in BD is a focus of our ongoing work and will be further elucidated in the future. rhythms, causing an amplitude decrease. CACNA1C knockdown alone had no effect on period, but attenuated the period lengthening action of lithium. CACNA1D (D-F) also caused increases in amplitude at baseline, and blocked lithium's ability to increase amplitude. Knockdown of CACNA1D shortened period, but had no effect on the period lengthening action of lithium.
CACNA1A (G-I) caused increases in amplitude at baseline, but had no effect on lithium's ability to increase amplitude. CACNA1A knockdown alone had no effect on period, but attenuated the period lengthening action of lithium. Knockdown of CACNB3 (J-L) decreased baseline amplitude, but had no effect on lithium's amplification of rhythms. CACNB3 knockdown had no statistically significant impact on period at baseline or after lithium. Sample sizes are as follows:
CACNA1C N= 12-15/ group, CACNA1D N= 3-6/ group, CACNA1A N= 4-6/ group, CACNB3 N= 9/ group. Normalized amplitude values for negative controls ± lithium were combined across experiments (total N=25 siRNA alone, N=31 siRNA+lithium). Values are means ± SEM;
Analyses performed by one-way ANOVA, *p < 0.05 in post-hoc tests. 
